company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,640972.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,640972.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,640972.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1154090.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2512248.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3666338.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3025366.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2889.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12987.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,174338.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,184436.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2840930.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2840930.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2840930.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,750000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3590930.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3300000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.08
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3300000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.08
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3329666.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2011.0,Q3,2011-07-01,2011-09-30,2012-12-21 11:07:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.08
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,758754.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,758754.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,758754.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1059202.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3059585.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4118787.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3360033.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,680341.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,680341.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2679692.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2679692.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2679692.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,750000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3429692.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3300000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.03
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3300000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.03
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3329666.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 17:20:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.03
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,758755.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,758755.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,758755.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,943857.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5018029.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5961886.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5203131.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,117144.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,117144.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5085987.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5085987.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5085987.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,750000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5835987.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3300000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.75
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3300000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.75
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3329266.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 08:15:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.75
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,523191.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,523191.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,523191.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,991062.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3318310.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4309372.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3786181.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1400807.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1400807.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5186988.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5186988.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5186988.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,1000000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6186988.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3300000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.86
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3300000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.86
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3329266.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 06:20:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.86
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,405405.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,405405.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,405405.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2183008.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4786640.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,24729483.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31699131.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-31293726.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,603322.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,603322.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30690404.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30690404.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30690404.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,-2500000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28190404.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5900000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.72
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5900000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.72
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6283238.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.72
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,405405.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,405405.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,405405.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2396854.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4832556.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7229410.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6824005.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3386143.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3386143.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10210148.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10210148.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10210148.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10210148.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16500000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.62
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16500000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.62
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16558297.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:16:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.62
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,405407.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,405407.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,405407.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2890505.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5132971.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8023476.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7618069.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5858848.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5858848.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13476917.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13476917.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13476917.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13476917.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16970519.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.79
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16970519.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.79
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17100000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:10:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.79
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,405407.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,405407.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,405407.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3115095.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8392628.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11507723.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11102316.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-20634757.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20634757.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31737073.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31737073.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31737073.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31737073.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19200000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.65
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19200000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.65
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19198923.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 17:20:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.65
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,405781.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,405781.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,405781.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4729546.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9583845.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14313391.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13907610.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1538748.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1538748.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12368862.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12368862.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12368862.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12367862.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18000000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.7
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18000000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.7
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18028731.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.7
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,405403.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,405403.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,405403.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5651127.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14292693.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19943820.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19538417.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-226490411.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-226490411.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-246028828.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-246028828.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-246028828.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-246028828.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19500000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-12.61
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19500000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-12.61
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19504748.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:15:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-12.61
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,445000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,445000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,445000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7955000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14919000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22874000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22429000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,55899000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,55899000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,33470000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33470000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,33470000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,33470000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20965094.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.6
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22204934.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.51
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20900000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 06:02:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.6
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,445000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,445000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,445000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9136000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27381000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36517000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-36072000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,228000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,228000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35844000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35844000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35843000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-35843000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21200000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.69
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21200000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.69
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21260303.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.69
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,446597.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,446597.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,446597.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11858873.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23718307.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35577180.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35130583.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,307411.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,307411.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34823172.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34823172.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34824172.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34824172.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20800000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.93
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20800000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.84
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20784000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.93
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1445000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1445000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1445000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13138000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27966000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41104000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-39659000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,272000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,272000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-39387000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39387000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39386000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-39386000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22100000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.78
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22100000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.78
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22171988.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:01:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.78
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,445000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,445000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,445000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20974000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28295000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,49269000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-48824000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,930000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,930000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-47894000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47894000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47894000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-47894000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24100000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.99
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24100000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.99
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24014092.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:16:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.99
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,445000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,445000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,445000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24742000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27487000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52229000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-51784000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,889000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,889000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-50895000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50895000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50895000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-50895000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24200000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.1
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24200000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.1
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24215000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:06:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.1
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,447000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,447000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,447000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60388000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28948000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,89336000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-88889000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,636000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,636000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-88253000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-88253000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-88254000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-88254000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23700000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.69
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23700000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.69
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23694000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.69
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,445000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,445000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,445000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,95865000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31980000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,127845000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-127400000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,726000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,726000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-126674000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-126674000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-126674000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-126674000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24500000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-5.17
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24500000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-5.17
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24495000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:33:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.17
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5520000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5520000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5520000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48715000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34900000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,83615000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-78095000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,796000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,796000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-77299000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-77299000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-77299000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-77299000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24600000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.14
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24600000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.14
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24612000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 06:04:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.14
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5177000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5177000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5177000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,52802000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35411000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,88213000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-83036000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7065000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1286000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5779000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-88815000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-88815000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-88815000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-88815000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24700000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.59
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24700000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.59
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24738000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:06:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.59
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13809000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13809000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13809000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,76214000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,51602000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,127816000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-114007000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7131000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1096000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6035000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-120042000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-120042000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-120042000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-120042000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24700000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.84
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24700000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.84
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24663000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.84
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21048000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21048000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,97000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,97000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20951000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,61082000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,43832000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,104914000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-83963000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7207000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1240000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5967000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-89930000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-89930000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-89930000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-89930000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24900000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.61
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24900000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.61
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24931000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:01:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.61
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30887000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30887000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,279000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,279000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30608000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,66925000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,44192000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,111117000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-80509000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7279000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1224000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6055000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-86564000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-86564000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-86564000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-86564000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25000000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.46
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25000000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.46
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25028000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:01:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.46
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,41334000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,41334000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,172000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,172000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41162000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,61356000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,45977000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,107333000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-66171000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7354000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,924000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6430000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-72601000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-72601000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-72601000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-72601000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25100000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.89
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25100000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.89
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25104000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:01:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.89
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,37687000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,37687000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,823000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,823000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36864000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,84335000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,57498000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,141833000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-104969000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7431000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1128000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6303000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-111272000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-111272000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-111272000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-111272000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25100000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.42
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25100000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.42
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25054000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.42
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,35963000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,35963000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,280000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,280000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,35683000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62467000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48672000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,111139000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-75456000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7509000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1375000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6134000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-81590000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-81590000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-81590000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-81590000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25300000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.22
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25300000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.22
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25309000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.22
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43575000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43575000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,713000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,713000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,42862000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,65224000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47415000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,112639000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-69777000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7589000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2173000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5416000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-75193000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-75193000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-75193000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-75193000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29100000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.58
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29100000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.58
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29199000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:02:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.58
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,46986000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,46986000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,519000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,519000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,46467000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,56812000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47941000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,104753000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-58286000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7671000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1503000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6168000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-64454000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-64454000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-64454000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-64454000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29600000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.18
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29600000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.18
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29615000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:03:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.18
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53280000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53280000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1007000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1007000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,52273000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,70971000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,63273000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,134244000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-81971000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7754000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1720000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6034000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-88005000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-88005000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-88005000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-88005000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28500000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.88
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28500000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.88
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28464000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.88
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,52252000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,52252000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,574000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,574000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,51678000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,77227000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,58396000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,135623000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-83945000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7839000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1514000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6325000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-90270000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-90270000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-90270000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-90270000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29800000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.03
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29800000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.03
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29760000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:03:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.03
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,66300000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,66300000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,677000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,677000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,65623000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,69683000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,59599000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,129282000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-63659000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9884000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2123000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7761000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-71420000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-71420000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-71420000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-71420000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31300000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.28
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31300000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.28
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31316000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:02:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.28
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,61950000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,61950000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,487000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,487000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,61463000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,76828000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,60168000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,136996000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-75533000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11795000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2495000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9300000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-84833000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-84833000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-84833000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-84833000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32800000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.59
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32800000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.59
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32717000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:03:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.59
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,71500000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,71500000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2474000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2474000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,69026000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,93680000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,64636000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,158316000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-89290000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11626000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2758000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8868000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-98158000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-98158000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-98158000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-98158000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31700000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.99
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31700000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.99
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31654000.0
Intercept Pharmaceuticals Inc,ICPT,,0001270073,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.99
